Introduction
Background
Endolymphatic hydrops by definition refers to increased hydraulic pressure within the inner ear's endolymphatic system. This pressure accumulation causes the following tetrad of symptoms: (1) fluctuating hearing loss (sometimes good or bad); (2) episodic vertigo (can be violent); (3) tinnitus or ringing in the ears (usually low-tone roaring); and (4) aural fullness (pressure, discomfort, fullness sensation in the ears).
Evaluating and managing dizziness and vertigo can be extremely difficult. The source of imbalance can range from easily treatable (eg, dehydration) to more ominous (eg, brain tumor). CNS problems need to be distinguished from circulation insufficiency, chemical and hormonal imbalances, and peripheral inner ear disorders. This distinction is often difficult. This article discusses peripheral inner ear disorders, specifically endolymphatic hydrops. Although it may be similar to articles on Ménière disease and syndrome, the focus will be the on pathophysiology of endolymphatic hydrops. (See eMedicine article Dizziness, Vertigo, and Imbalance for related information.)
Endolymphatic hydrops often is used synonymously with Ménière disease and Ménière syndrome, which are thought to result from increased pressure within the endolymphatic system.
Ménière disease is idiopathic, whereas Ménière syndrome is secondary to another disease process (eg, thyroid disease, inner ear inflammation due to syphilis). This distinction is analogous to that in Bell palsy. If the source of facial paralysis is known, the diagnosis is not Bell palsy. Similarly, if the cause of vertigo is known, the diagnosis cannot be Ménière disease. Ménière syndrome may be secondary to various processes that interfere with normal production or resorption of endolymph (eg, endocrine abnormalities, trauma, electrolyte imbalance, autoimmune dysfunction, medications, infections [especially parasitic], hyperlipidemia).
Pathophysiology
The endolymph and perilymph (ie, fluids that fill the chambers of the inner ear) are separated by thin membranes that house the neural apparatus of hearing and balance. Fluctuations in pressure stress these nerve-rich membranes, causing hearing disturbance, tinnitus, vertigo, imbalance, and a pressure sensation in the ear.Attacks of hydrops probably are caused by an increase in endolymphatic pressure, which, in turn, causes a break in the membrane that separates the perilymph (potassium-poor extracellular fluid) and the endolymph (potassium-rich intracellular fluid). The resultant chemical mixture bathes the vestibular nerve receptors, leading to a depolarization blockade and transient loss of function. The sudden change in the rate of vestibular nerve firing creates an acute vestibular imbalance (ie, vertigo).
The physical distention caused by increased endolymphatic pressure also leads to a mechanical disturbance of the auditory and otolithic organs. Since the utricle and saccule are responsible for linear and translational motion detection (as opposed to angular and rotational acceleration), irritation of these organs may produce nonrotational vestibular symptoms.
The organ of Corti is disturbed mechanically. Distortion of the basilar membrane and the inner and outer hair cells may cause hearing loss and/or tinnitus. Since the apex of the cochlea is wound much tighter than the base, the apex is more sensitive to pressure changes than the base. This explains why hydrops preferentially affects low frequencies (at the apex) as opposed to high frequencies (at the relatively wider base). Symptoms improve after the membrane is repaired as sodium and potassium concentrations revert to normal.
Frequency
United States
Although probably underestimated, a prevalence of 1,000 cases per 100,000 population is a reasonable approximation. Familial predisposition may be a factor, since half of patients have a significant family history.
Mortality/Morbidity
Although the disease itself is not fatal, it can be associated with significant morbidity.
- Vertigo can cause accidents and falls, which can be devastating.
- Hearing loss often is progressive over time.
- Many patients can no longer work and are forced to claim disability.
Sex
The female-to-male ratio is 1.8:1.
Age
- The mean age among treatment groups in some studies ranged from 49-67 years.
- Ménière can be seen at almost all ages, but the typical onset begins at early to middle adulthood.
Clinical
History
The typical history involves episodic attacks of true whirling vertigo, which usually are preceded by a variable sense of ear pressure and fullness, decreased hearing, and a low-tone roaring tinnitus.
- The vertiginous attacks typically last minutes to hours, and often are associated with severe nausea and vomiting.
- After the acute attack, patients generally feel tired, unsteady, and nauseated for hours to days.
- The timing and frequency of attacks is variable. Some patients can regularly predict an attack while others note a completely random pattern. Attacks may be linked to dietary triggers, the menstrual cycle, or psychosocial stresses.
- Between episodes, some patients are completely symptom free. Many notice progressive deterioration of hearing and balance function with each successive attack.
Physical
Examination results vary, depending upon the phase of disease. During remission, physical examination findings may be completely normal, particularly if the patient is symptom free.
- During an acute attack, the patient has severe vertigo.
- Patients are often in significant distress. Many present to the physician's office clutching a bucket and towel with signs of recent vomiting.
- Patients are sometimes diaphoretic and pale.
- Vital signs may show elevated blood pressure, pulse, and respiration.
- Significant nystagmus may be present.
- Pneumo-otoscopy of the affected ear may elicit symptoms or cause nystagmus.
- The Romberg test generally shows significant instability and worsening when the eyes are closed.
- The Fukuda marching step test may show significant deviation (if the patient can stand with closed eyes).
- The Dix-Hallpike test result may be positive, indicating coexisting benign positional vertigo.
- Hearing usually is affected.
- The Weber tuning fork test usually lateralizes away from the affected ear.
- The Rinne test usually indicates that air conduction remains better than bone conduction.
- Complete neurologic evaluation is important. New-onset vertigo might be an early sign of stroke, migraine, or brainstem compression that may require emergent evaluation and care.
Causes
Based on semantics, Ménière disease is defined as idiopathic. In other words, if the cause is known, the disease process can no longer be called Ménière's disease. However, since the root of the problem is elevated endolymphatic pressure, the causes of endolymphatic hydrops will be discussed.
- Several disorders may cause increased endolymph pressure, including metabolic disturbances, hormonal balance, trauma, and various infections.
- Autoimmune diseases, such as lupus and rheumatoid arthritis, may cause an inflammatory response within the labyrinth.
- Allergy also has been implicated in many patients with difficult to treat Meniere disease.
- Food triggers are also important factors in the generation of hydrops.
More on Endolymphatic Hydrops |
Overview: Endolymphatic Hydrops |
| Differential Diagnoses & Workup: Endolymphatic Hydrops |
| Treatment & Medication: Endolymphatic Hydrops |
| Follow-up: Endolymphatic Hydrops |
| Multimedia: Endolymphatic Hydrops |
| References |
| Next Page » |
References
Huang W, Liu F, Gao B, Zhou J. Clinical long-term effects of Meniett pulse generator for Meniere's disease. Acta Otolaryngol. Oct 15 2008;1-7. [Medline].
Dornhoffer JL, King D. The effect of the Meniett device in patients with Meniere's disease: long-term results. Otol Neurotol. Sep 2008;29(6):868-74. [Medline].
Mattox DE, Reichert M. Meniett device for Meniere's disease: use and compliance at 3 to 5 years. Otol Neurotol. Jan 2008;29(1):29-32. [Medline].
Silverstein H, Smouha E, Jones R. Natural history vs. surgery for Meniere's disease. Otolaryngol Head Neck Surg. Jan 1989;100(1):6-16. [Medline].
Bretlau P, Thomsen J, Tos M, Johnsen NJ. Placebo effect in surgery for Meniere's disease: nine-year follow-up. Am J Otol. Jul 1989;10(4):259-61. [Medline].
Monsell EM, Wiet RJ. Endolymphatic sac surgery: methods of study and results. Am J Otol. Sep 1988;9(5):396-402. [Medline].
Glasscock ME 3rd, Jackson CG, Poe DS, Johnson GD. What I think of sac surgery in 1989. Am J Otol. May 1989;10(3):230-3. [Medline].
Shea JJ Jr, Ge X. Streptomycin perfusion of the labyrinth through the round window plus intravenous streptomycin. Otolaryngol Clin North Am. Apr 1994;27(2):317-24. [Medline].
Pyykko I, Ishizaki H, Kaasinen S, Aalto H. Intratympanic gentamicin in bilateral Meniere's disease. Otolaryngol Head Neck Surg. Feb 1994;110(2):162-7. [Medline].
Densert B, Sass K. Control of symptoms in patients with Meniere's disease using middle ear pressure applications: two years follow-up. Acta Otolaryngol. Jul 2001;121(5):616-21. [Medline].
Ernst A, Basta D, Seidl RO, et al. Management of posttraumatic vertigo. Otolaryngol Head Neck Surg. Apr 2005;132(4):554-8. [Medline].
Green JD Jr, Blum DJ, Harner SG. Longitudinal followup of patients with Meniere's disease. Otolaryngol Head Neck Surg. Jun 1991;104(6):783-8. [Medline].
Semaan MT, Alagramam KN, Megerian CA. The basic science of Meniere's disease and endolymphatic hydrops. Curr Opin Otolaryngol Head Neck Surg. Oct 2005;13(5):301-7. [Medline].
Shea JJ Jr. Classification of Meniere's disease. Am J Otol. May 1993;14(3):224-9. [Medline].
Silverstein H, Lewis WB, Jackson LE, Rosenberg SI, Thompson JH, Hoffmann KK. Changing trends in the surgical treatment of Meniere's disease: results of a 10-year survey. Ear Nose Throat J. Mar 2003;82(3):185-7, 191-4. [Medline].
Further Reading
Keywords
Ménière's disease, Ménière disease, Ménière's syndrome, Ménière syndrome, cochleovestibular hydrops, cochlear hydrops, vestibular hydrops, endolymphatic system, inner ear, dizziness, vertigo, inner ear disorders, endocrine abnormalities, trauma, electrolyte imbalance, autoimmune dysfunction, medications, parasitic infections, hyperlipidemia, endolymph resorption, hearing loss
Overview: Endolymphatic Hydrops